Your browser doesn't support javascript.
loading
Adaptive behavior in adolescents and adults with Down syndrome: Results from a 6-month longitudinal study.
Spiridigliozzi, Gail A; Goeldner, Celia; Edgin, Jamie; Hart, Sarah J; Noeldeke, Jana; Squassante, Lisa; Visootsak, Jeannie; Heller, James H; Khwaja, Omar; Kishnani, Priya S; Liogier d'Ardhuy, Xavier.
Afiliação
  • Spiridigliozzi GA; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
  • Goeldner C; F. Hoffmann-La Roche, Roche Pharma Research and Early Development, Neuroscience, Roche Innovation Center Basel, Basel, Switzerland.
  • Edgin J; Department of Psychology, University of Arizona, Tucson, Arizona.
  • Hart SJ; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
  • Noeldeke J; F. Hoffmann-La Roche, Roche Pharma Research and Early Development, Neuroscience, Roche Innovation Center Basel, Basel, Switzerland.
  • Squassante L; F. Hoffmann-La Roche, Roche Pharma Research and Early Development, Neuroscience, Roche Innovation Center Basel, Basel, Switzerland.
  • Visootsak J; F. Hoffmann-La Roche, Roche Pharma Research and Early Development, Neuroscience, Roche Innovation Center, New York, New York.
  • Khwaja O; F. Hoffmann-La Roche, Roche Pharma Research and Early Development, Neuroscience, Roche Innovation Center Basel, Basel, Switzerland.
  • Kishnani PS; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
  • Liogier d'Ardhuy X; F. Hoffmann-La Roche, Roche Pharma Research and Early Development, Neuroscience, Roche Innovation Center Basel, Basel, Switzerland.
Am J Med Genet A ; 179(1): 85-93, 2019 01.
Article em En | MEDLINE | ID: mdl-30569586
Measures of adaptive behavior are important in the assessment and treatment of individuals with intellectual disabilities (ID). The purpose of the current study was to evaluate the stability of an established and a novel measure of adaptive behavior over time, and their suitability as outcome measures in clinical trials targeting individuals with Down syndrome (DS). This 6-month, longitudinal, noninterventional, multinational study included adolescents (12-17 years) and adults (18-30 years) with DS. Participants were from seven countries (11 different sites) with English, Spanish and French as their native language. The Vineland Adaptive Behavior Scales-II (VABS-II) and a newly developed Clinician Global Impression (CGI) scale were administered at baseline, 1 and 6 months. Adults had lower composite standard scores on all domains of the VABS-II compared with adolescents. The communication domain was a weakness relative to the socialization and daily living skills domains on the VABS-II and the CGI-Severity scale. These findings were stable over 6 months, as exhibited by high intraclass correlations (>0.75). These results provide valuable baseline data for use in trial design and endpoint selection for studies including individuals with DS. ClinicalTrials.gov identifier: NCT01580384.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adaptação Psicológica / Síndrome de Down / Deficiência Intelectual Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Am J Med Genet A Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adaptação Psicológica / Síndrome de Down / Deficiência Intelectual Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Am J Med Genet A Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article